These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22657748)

  • 1. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Garrett SB; Doyle SR; Floyd AS; Knox PC; Botero C; Kelly TM; Killeen TK; Hayes C; Kau'i Baumhofer N; Seamans C; Zammarelli L
    J Subst Abuse Treat; 2013 Jan; 44(1):103-14. PubMed ID: 22657748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age differences in outcomes among patients in the "Stimulant Abuser Groups to Engage in 12-Step" (STAGE-12) intervention.
    Garrett SB; Doyle SR; Peavy KM; Wells EA; Owens MD; Shores-Wilson K; DiCenzo J; Donovan DM
    J Subst Abuse Treat; 2018 Jan; 84():21-29. PubMed ID: 29195590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?
    Wells EA; Donovan DM; Daley DC; Doyle SR; Brigham G; Garrett SB; Ingalsbe MH; Hatch-Maillette MA; Perl HI; Walker R
    J Subst Abuse Treat; 2014 Oct; 47(4):265-74. PubMed ID: 25064421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.
    Hatch-Maillette M; Wells EA; Doyle SR; Brigham GS; Daley D; DiCenzo J; Donovan D; Garrett S; Horigian VE; Jenkins L; Killeen T; Owens M; Perl HI
    J Subst Abuse Treat; 2016 Sep; 68():74-82. PubMed ID: 27431050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and Outcomes of Twelve-Step Sponsorship of Stimulant Users: Secondary Analyses of a Multisite Randomized Clinical Trial.
    Wendt DC; Hallgren KA; Daley DC; Donovan DM
    J Stud Alcohol Drugs; 2017 Mar; 78(2):287-295. PubMed ID: 28317510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes.
    Timko C; Debenedetti A; Billow R
    Addiction; 2006 May; 101(5):678-88. PubMed ID: 16669901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes.
    Timko C; DeBenedetti A
    Drug Alcohol Depend; 2007 Oct; 90(2-3):270-9. PubMed ID: 17524574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically relevant characteristics associated with early treatment drug use versus abstinence.
    Cochran G; Stitzer M; Nunes EV; Hu MC; Campbell A
    Addict Sci Clin Pract; 2014 Apr; 9(1):6. PubMed ID: 24708748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial.
    Manning V; Best D; Faulkner N; Titherington E; Morinan A; Keaney F; Gossop M; Strang J
    Drug Alcohol Depend; 2012 Nov; 126(1-2):131-7. PubMed ID: 22677458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness.
    McDonell MG; Srebnik D; Angelo F; McPherson S; Lowe JM; Sugar A; Short RA; Roll JM; Ries RK
    Am J Psychiatry; 2013 Jan; 170(1):94-101. PubMed ID: 23138961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does treatment fidelity predict client outcomes in 12-Step Facilitation for stimulant abuse?
    Guydish J; Campbell BK; Manuel JK; Delucchi KL; Le T; Peavy KM; McCarty D
    Drug Alcohol Depend; 2014 Jan; 134():330-336. PubMed ID: 24286966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.
    Trivedi MH; Greer TL; Grannemann BD; Church TS; Somoza E; Blair SN; Szapocznik J; Stoutenberg M; Rethorst C; Warden D; Ring KM; Walker R; Morris DW; Kosinski AS; Kyle T; Marcus B; Crowell B; Oden N; Nunes E
    Trials; 2011 Sep; 12():206. PubMed ID: 21929768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes with the ARISE approach to engaging reluctant drug- and alcohol-dependent individuals in treatment.
    Landau J; Stanton MD; Brinkman-Sull D; Ikle D; McCormick D; Garrett J; Baciewicz G; Shea RR; Browning A; Wamboldt F
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):711-48. PubMed ID: 15624546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
    Stitzer ML; Petry NM; Peirce J
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S61-9. PubMed ID: 20307797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive referral to 12-step dual-focused mutual-help groups.
    Timko C; Sutkowi A; Cronkite RC; Makin-Byrd K; Moos RH
    Drug Alcohol Depend; 2011 Nov; 118(2-3):194-201. PubMed ID: 21515004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent substance abuse treatment clinicians' self-help meeting referral practices and adolescent attendance rates.
    Passetti LL; Godley SH
    J Psychoactive Drugs; 2008 Mar; 40(1):29-40. PubMed ID: 18472663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.